Loading…
Vascular smooth muscle cell dysfunction in neurodegeneration
Vascular smooth muscle cells (VSMCs) are the key moderators of cerebrovascular dynamics in response to the brain’s oxygen and nutrient demands. Crucially, VSMCs may provide a sensitive biomarker for neurodegenerative pathologies where vasculature is compromised. An increasing body of research sugges...
Saved in:
Published in: | Frontiers in neuroscience 2022-11, Vol.16, p.1010164-1010164 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c445t-a3fae7421179db2fb9dc567a73569acc7886d145e6e99eb57dca5601e137a023 |
---|---|
cites | cdi_FETCH-LOGICAL-c445t-a3fae7421179db2fb9dc567a73569acc7886d145e6e99eb57dca5601e137a023 |
container_end_page | 1010164 |
container_issue | |
container_start_page | 1010164 |
container_title | Frontiers in neuroscience |
container_volume | 16 |
creator | Hayes, Genevieve Pinto, Joana Sparks, Sierra N. Wang, Congxiyu Suri, Sana Bulte, Daniel P. |
description | Vascular smooth muscle cells (VSMCs) are the key moderators of cerebrovascular dynamics in response to the brain’s oxygen and nutrient demands. Crucially, VSMCs may provide a sensitive biomarker for neurodegenerative pathologies where vasculature is compromised. An increasing body of research suggests that VSMCs have remarkable plasticity and their pathophysiology may play a key role in the complex process of neurodegeneration. Furthermore, extrinsic risk factors, including environmental conditions and traumatic events can impact vascular function through changes in VSMC morphology. VSMC dysfunction can be characterised at the molecular level both preclinically, and clinically
ex vivo
. However the identification of VSMC dysfunction in living individuals is important to understand changes in vascular function at the onset and progression of neurological disorders such as dementia, Alzheimer’s disease, and Parkinson’s disease. A promising technique to identify changes in the state of cerebral smooth muscle is cerebrovascular reactivity (CVR) which reflects the intrinsic dynamic response of blood vessels in the brain to vasoactive stimuli in order to modulate regional cerebral blood flow (CBF). In this work, we review the role of VSMCs in the most common neurodegenerative disorders and identify physiological systems that may contribute to VSMC dysfunction. The evidence collected here identifies VSMC dysfunction as a strong candidate for novel therapeutics to combat the development and progression of neurodegeneration, and highlights the need for more research on the role of VSMCs and cerebrovascular dynamics in healthy and diseased states. |
doi_str_mv | 10.3389/fnins.2022.1010164 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_98fd2fbc651241a0b2fb72bd4d39f260</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_98fd2fbc651241a0b2fb72bd4d39f260</doaj_id><sourcerecordid>2740907646</sourcerecordid><originalsourceid>FETCH-LOGICAL-c445t-a3fae7421179db2fb9dc567a73569acc7886d145e6e99eb57dca5601e137a023</originalsourceid><addsrcrecordid>eNpVkU1LxDAQhosouK7-AU89etk1X00aEEHEjwXBi4i3ME2ma5c2WZNW8N_buosoc5hhZnjeYd4sO6dkyXmpL2vf-LRkhLElJWNIcZDNqJRsIQr-dvinPs5OUtoQIlkp2Cy7eoVkhxZinroQ-ve8G5JtMbfYtrn7SvXgbd8Enzc-9zjE4HCNHiNMzdPsqIY24dk-z7OX-7uX28fF0_PD6vbmaWGFKPoF8BpQCUap0q5idaWdLaQCxQupwVpVltJRUaBErbEqlLNQSEKRcgWE8Xm22mFdgI3ZxqaD-GUCNOanEeLaQOyb8Wyjy9qNAlYWlAkKZFJTrHLCcV0zSUbW9Y61HaoOnUXfR2j_Qf9PfPNu1uHTaFkKKcQIuNgDYvgYMPWma9L0LfAYhmSYEkQTJYUcV9lu1caQUsT6V4YSM9lmfmwzk21mbxv_BrPyjm4</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2740907646</pqid></control><display><type>article</type><title>Vascular smooth muscle cell dysfunction in neurodegeneration</title><source>PubMed Central (Open Access)</source><creator>Hayes, Genevieve ; Pinto, Joana ; Sparks, Sierra N. ; Wang, Congxiyu ; Suri, Sana ; Bulte, Daniel P.</creator><creatorcontrib>Hayes, Genevieve ; Pinto, Joana ; Sparks, Sierra N. ; Wang, Congxiyu ; Suri, Sana ; Bulte, Daniel P.</creatorcontrib><description>Vascular smooth muscle cells (VSMCs) are the key moderators of cerebrovascular dynamics in response to the brain’s oxygen and nutrient demands. Crucially, VSMCs may provide a sensitive biomarker for neurodegenerative pathologies where vasculature is compromised. An increasing body of research suggests that VSMCs have remarkable plasticity and their pathophysiology may play a key role in the complex process of neurodegeneration. Furthermore, extrinsic risk factors, including environmental conditions and traumatic events can impact vascular function through changes in VSMC morphology. VSMC dysfunction can be characterised at the molecular level both preclinically, and clinically
ex vivo
. However the identification of VSMC dysfunction in living individuals is important to understand changes in vascular function at the onset and progression of neurological disorders such as dementia, Alzheimer’s disease, and Parkinson’s disease. A promising technique to identify changes in the state of cerebral smooth muscle is cerebrovascular reactivity (CVR) which reflects the intrinsic dynamic response of blood vessels in the brain to vasoactive stimuli in order to modulate regional cerebral blood flow (CBF). In this work, we review the role of VSMCs in the most common neurodegenerative disorders and identify physiological systems that may contribute to VSMC dysfunction. The evidence collected here identifies VSMC dysfunction as a strong candidate for novel therapeutics to combat the development and progression of neurodegeneration, and highlights the need for more research on the role of VSMCs and cerebrovascular dynamics in healthy and diseased states.</description><identifier>ISSN: 1662-453X</identifier><identifier>ISSN: 1662-4548</identifier><identifier>EISSN: 1662-453X</identifier><identifier>DOI: 10.3389/fnins.2022.1010164</identifier><language>eng</language><publisher>Frontiers Media S.A</publisher><subject>Alzheimer’s disease ; cerebral blood flow ; cerebrovascular reactivity ; dementia ; neurodegeneration ; Neuroscience ; vascular smooth muscle cells</subject><ispartof>Frontiers in neuroscience, 2022-11, Vol.16, p.1010164-1010164</ispartof><rights>Copyright © 2022 Hayes, Pinto, Sparks, Wang, Suri and Bulte. 2022 Hayes, Pinto, Sparks, Wang, Suri and Bulte</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c445t-a3fae7421179db2fb9dc567a73569acc7886d145e6e99eb57dca5601e137a023</citedby><cites>FETCH-LOGICAL-c445t-a3fae7421179db2fb9dc567a73569acc7886d145e6e99eb57dca5601e137a023</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684644/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684644/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>Hayes, Genevieve</creatorcontrib><creatorcontrib>Pinto, Joana</creatorcontrib><creatorcontrib>Sparks, Sierra N.</creatorcontrib><creatorcontrib>Wang, Congxiyu</creatorcontrib><creatorcontrib>Suri, Sana</creatorcontrib><creatorcontrib>Bulte, Daniel P.</creatorcontrib><title>Vascular smooth muscle cell dysfunction in neurodegeneration</title><title>Frontiers in neuroscience</title><description>Vascular smooth muscle cells (VSMCs) are the key moderators of cerebrovascular dynamics in response to the brain’s oxygen and nutrient demands. Crucially, VSMCs may provide a sensitive biomarker for neurodegenerative pathologies where vasculature is compromised. An increasing body of research suggests that VSMCs have remarkable plasticity and their pathophysiology may play a key role in the complex process of neurodegeneration. Furthermore, extrinsic risk factors, including environmental conditions and traumatic events can impact vascular function through changes in VSMC morphology. VSMC dysfunction can be characterised at the molecular level both preclinically, and clinically
ex vivo
. However the identification of VSMC dysfunction in living individuals is important to understand changes in vascular function at the onset and progression of neurological disorders such as dementia, Alzheimer’s disease, and Parkinson’s disease. A promising technique to identify changes in the state of cerebral smooth muscle is cerebrovascular reactivity (CVR) which reflects the intrinsic dynamic response of blood vessels in the brain to vasoactive stimuli in order to modulate regional cerebral blood flow (CBF). In this work, we review the role of VSMCs in the most common neurodegenerative disorders and identify physiological systems that may contribute to VSMC dysfunction. The evidence collected here identifies VSMC dysfunction as a strong candidate for novel therapeutics to combat the development and progression of neurodegeneration, and highlights the need for more research on the role of VSMCs and cerebrovascular dynamics in healthy and diseased states.</description><subject>Alzheimer’s disease</subject><subject>cerebral blood flow</subject><subject>cerebrovascular reactivity</subject><subject>dementia</subject><subject>neurodegeneration</subject><subject>Neuroscience</subject><subject>vascular smooth muscle cells</subject><issn>1662-453X</issn><issn>1662-4548</issn><issn>1662-453X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkU1LxDAQhosouK7-AU89etk1X00aEEHEjwXBi4i3ME2ma5c2WZNW8N_buosoc5hhZnjeYd4sO6dkyXmpL2vf-LRkhLElJWNIcZDNqJRsIQr-dvinPs5OUtoQIlkp2Cy7eoVkhxZinroQ-ve8G5JtMbfYtrn7SvXgbd8Enzc-9zjE4HCNHiNMzdPsqIY24dk-z7OX-7uX28fF0_PD6vbmaWGFKPoF8BpQCUap0q5idaWdLaQCxQupwVpVltJRUaBErbEqlLNQSEKRcgWE8Xm22mFdgI3ZxqaD-GUCNOanEeLaQOyb8Wyjy9qNAlYWlAkKZFJTrHLCcV0zSUbW9Y61HaoOnUXfR2j_Qf9PfPNu1uHTaFkKKcQIuNgDYvgYMPWma9L0LfAYhmSYEkQTJYUcV9lu1caQUsT6V4YSM9lmfmwzk21mbxv_BrPyjm4</recordid><startdate>20221110</startdate><enddate>20221110</enddate><creator>Hayes, Genevieve</creator><creator>Pinto, Joana</creator><creator>Sparks, Sierra N.</creator><creator>Wang, Congxiyu</creator><creator>Suri, Sana</creator><creator>Bulte, Daniel P.</creator><general>Frontiers Media S.A</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20221110</creationdate><title>Vascular smooth muscle cell dysfunction in neurodegeneration</title><author>Hayes, Genevieve ; Pinto, Joana ; Sparks, Sierra N. ; Wang, Congxiyu ; Suri, Sana ; Bulte, Daniel P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c445t-a3fae7421179db2fb9dc567a73569acc7886d145e6e99eb57dca5601e137a023</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Alzheimer’s disease</topic><topic>cerebral blood flow</topic><topic>cerebrovascular reactivity</topic><topic>dementia</topic><topic>neurodegeneration</topic><topic>Neuroscience</topic><topic>vascular smooth muscle cells</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hayes, Genevieve</creatorcontrib><creatorcontrib>Pinto, Joana</creatorcontrib><creatorcontrib>Sparks, Sierra N.</creatorcontrib><creatorcontrib>Wang, Congxiyu</creatorcontrib><creatorcontrib>Suri, Sana</creatorcontrib><creatorcontrib>Bulte, Daniel P.</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Frontiers in neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hayes, Genevieve</au><au>Pinto, Joana</au><au>Sparks, Sierra N.</au><au>Wang, Congxiyu</au><au>Suri, Sana</au><au>Bulte, Daniel P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Vascular smooth muscle cell dysfunction in neurodegeneration</atitle><jtitle>Frontiers in neuroscience</jtitle><date>2022-11-10</date><risdate>2022</risdate><volume>16</volume><spage>1010164</spage><epage>1010164</epage><pages>1010164-1010164</pages><issn>1662-453X</issn><issn>1662-4548</issn><eissn>1662-453X</eissn><abstract>Vascular smooth muscle cells (VSMCs) are the key moderators of cerebrovascular dynamics in response to the brain’s oxygen and nutrient demands. Crucially, VSMCs may provide a sensitive biomarker for neurodegenerative pathologies where vasculature is compromised. An increasing body of research suggests that VSMCs have remarkable plasticity and their pathophysiology may play a key role in the complex process of neurodegeneration. Furthermore, extrinsic risk factors, including environmental conditions and traumatic events can impact vascular function through changes in VSMC morphology. VSMC dysfunction can be characterised at the molecular level both preclinically, and clinically
ex vivo
. However the identification of VSMC dysfunction in living individuals is important to understand changes in vascular function at the onset and progression of neurological disorders such as dementia, Alzheimer’s disease, and Parkinson’s disease. A promising technique to identify changes in the state of cerebral smooth muscle is cerebrovascular reactivity (CVR) which reflects the intrinsic dynamic response of blood vessels in the brain to vasoactive stimuli in order to modulate regional cerebral blood flow (CBF). In this work, we review the role of VSMCs in the most common neurodegenerative disorders and identify physiological systems that may contribute to VSMC dysfunction. The evidence collected here identifies VSMC dysfunction as a strong candidate for novel therapeutics to combat the development and progression of neurodegeneration, and highlights the need for more research on the role of VSMCs and cerebrovascular dynamics in healthy and diseased states.</abstract><pub>Frontiers Media S.A</pub><doi>10.3389/fnins.2022.1010164</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1662-453X |
ispartof | Frontiers in neuroscience, 2022-11, Vol.16, p.1010164-1010164 |
issn | 1662-453X 1662-4548 1662-453X |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_98fd2fbc651241a0b2fb72bd4d39f260 |
source | PubMed Central (Open Access) |
subjects | Alzheimer’s disease cerebral blood flow cerebrovascular reactivity dementia neurodegeneration Neuroscience vascular smooth muscle cells |
title | Vascular smooth muscle cell dysfunction in neurodegeneration |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T10%3A30%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Vascular%20smooth%20muscle%20cell%20dysfunction%20in%20neurodegeneration&rft.jtitle=Frontiers%20in%20neuroscience&rft.au=Hayes,%20Genevieve&rft.date=2022-11-10&rft.volume=16&rft.spage=1010164&rft.epage=1010164&rft.pages=1010164-1010164&rft.issn=1662-453X&rft.eissn=1662-453X&rft_id=info:doi/10.3389/fnins.2022.1010164&rft_dat=%3Cproquest_doaj_%3E2740907646%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c445t-a3fae7421179db2fb9dc567a73569acc7886d145e6e99eb57dca5601e137a023%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2740907646&rft_id=info:pmid/&rfr_iscdi=true |